|
|
||||||||
The Journal of Immunology, Vol 147, Issue 8 2706-2712, Copyright © 1991 by American Association of Immunologists
ARTICLES |
DP Harris, HM Vordermeier, E Roman, R Lathigra, SJ Brett, C Moreno and J Ivanyi
MRC Tuberculosis and Related Infections Unit, Royal Postgraduate Medical School, London, UK.
Fifteen overlapping synthetic peptides, spanning the entire amino acid sequence of the Mycobacterium tuberculosis 19-kDa protein, were used to identify epitopes recognized by murine T cells. Five of the 15 peptides tested were able to elicit in vitro lymph node T cell proliferative responses in C57BL/10 mice primed by footpad inoculation with homologous peptide. Analysis in congenic strains of mice revealed H-2 restriction in the response to four peptides. However, one peptide, 19.7 (residues 61 to 80), induced T cell responses in all four haplotypes tested. This peptide was also unique in being able to stimulate lymph node cells from C57BL/10 mice immunized with recombinant 19-kDa protein, killed M. tuberculosis, or live bacillus Calmette Guerin infection. T cell lines specific for peptide 19.7 were of the CD4 phenotype. Significantly, sequence analysis revealed that residues 61 to 80 of the 19-kDa protein exhibited considerable homology with a single 20-amino acid sequence (residues 120 to 140), but not with any other region of the 28-kDa protein expressed in Mycobacterium leprae. This finding is the first evidence of epitope-restricted homology between otherwise structurally unrelated microbial Ag.
This article has been cited by other articles:
![]() |
Y. Narayana, B. Joshi, V. M. Katoch, K. C. Mishra, and K. N. Balaji Differential B-Cell Responses Are Induced by Mycobacterium tuberculosis PE Antigens Rv1169c, Rv0978c, and Rv1818c Clin. Vaccine Immunol., October 1, 2007; 14(10): 1334 - 1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lyashchenko, C. Manca, R. Colangeli, A. Heijbel, A. Williams, and M. L. Gennaro Use of Mycobacterium tuberculosis Complex-Specific Antigen Cocktails for a Skin Test Specific for Tuberculosis Infect. Immun., August 1, 1998; 66(8): 3606 - 3610. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |